Notably, USP39 depletion recapitulated 5'-splice-site-specific splicing patterns previously described, thereby validating both the mechanism of action and the therapeutic relevance of this approach-particularly for modulating splicing-associated disease pathways such as cancer and retinitis pigmentosa. Here, USP39 is linked to cancer.